ResearcherAgostino Gemelli University PolyclinicActive in the last 2 years
Andrea Di Giorgio
Matched on ORCID iD 0000-0003-3981-1145; OpenAlex author ID A5011430011. Sources: ClinicalTrials.gov.
Their work
- Papers
- 3
- Trials
- 1 (principal investigator on 1)
- Grants
- 0
- Labs led
- 0
- Collaborators
- 8
2020: 1 paper · 2021: none · 2022: 1 trial · 2023: none · 2024: 1 paper · 2025: none · 2026: 1 paper
Papers 3
- Pressurized intraperitoneal aerosol chemotherapy (PIPAC) for pancreatic cancer peritoneal metastases: A retrospective multicentric study from the ISSPP PIPAC D… Co-author DOI 10.1016/j.ejso.2026.112078↗
- Combined Nabpaclitaxel pressurized intraPeritoneal aerosol chemotherapy with systemic Nabpaclitaxel-Gemcitabine chemotherapy for pancreatic cancer peritoneal m… Co-author DOI 10.1515/pp-2024-0010↗
- Pressurized intraperitoneal aerosol chemotherapy with cisplatin and doxorubicin or oxaliplatin for peritoneal metastasis from pancreatic adenocarcinoma and cho… Co-author DOI 10.1177/1758835920940887↗
Trials 1
Closest collaborators
The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Fabio Pacelli · 3 shared papers, 2020–2026 · strength 0.59
- Paper Pressurized intraperitoneal aerosol chemotherapy (PIPAC) for pancreatic cancer peritoneal metastases: A retrospective m… DOI 10.1016/j.ejso.2026.112078↗
- Paper Combined Nabpaclitaxel pressurized intraPeritoneal aerosol chemotherapy with systemic Nabpaclitaxel-Gemcitabine chemoth… DOI 10.1515/pp-2024-0010↗
- Paper Pressurized intraperitoneal aerosol chemotherapy with cisplatin and doxorubicin or oxaliplatin for peritoneal metastasi… DOI 10.1177/1758835920940887↗
- Claus Wilki Fristrup · 1 shared paper, 2026 · strength 0.27
- Michael Bau Mortensen · 1 shared paper, 2026 · strength 0.27
- Sönke Detlefsen · 1 shared paper, 2026 · strength 0.27
- Sergio Alfieri · 1 shared paper, 2024 · strength 0.20
- Lisa Salvatore · 1 shared paper, 2024 · strength 0.20
- Giampaolo Tortora · 1 shared paper, 2024 · strength 0.20
- Carmine Carbone · 1 shared paper, 2024 · strength 0.20
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.